Iribarren ME, et al. Experience with Mepolizumab in a cohort of patients with eosinophilic severe persistent asthma. P2520. ERS 2019, 28 sep.-2 okt. 2019, Madrid, Spanje.
Karijn Suijkerbuijk hoogleraar Immunotherapie UMC Utrecht
aug 2022 | Immuuntherapie